John Chuback – Blood Clots: The Silent Killer
John Chuback, Founder of Vein and Lymphatic Summit, posted on LinkedIn:
”Blood clots can turn deadly in minutes, yet most people don’t know the signs.
They can form after sitting too long on a flight, from an injury, or even following surgery. What many don’t realize is that blood clots don’t always cause pain. Sometimes there are no clear symptoms until it is too late.
A clot in the leg, called deep vein thrombosis (DVT), can break off and travel to the lungs. This is known as a pulmonary embolism, and it can kill very quickly.
The warning signs are critical to recognize. Swelling in one leg, sudden sharp chest pain, trouble breathing, coughing up blood, or feeling faint and lightheaded should never be ignored.
If someone has recently had surgery or been sitting for long hours and suddenly develops chest pain or shortness of breath, act immediately. Go to the emergency department and say, “I’m worried this could be a blood clot.”
Every minute matters. Knowing the signs and responding quickly can save lives.
Watch my full breakdown here.
What do you think? Do most people underestimate how dangerous blood clots really are?”
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
